Wong K W, D'Amico D J, Oum B S, Baker P A, Kenyon K R
Howe Laboratory of Ophthalmology, Harvard Medical School, Boston, MA.
Graefes Arch Clin Exp Ophthalmol. 1990;228(1):40-3. doi: 10.1007/BF02764289.
Rifampin, the most potent anti-staphylococcal drug known, was examined for its penetration into the aqueous and vitreous of rabbits after a single oral dose of 150 mg, 300 mg, or 600 mg. Maximum levels after the 150 mg dose were achieved at 4 h and were 4.2 micrograms/ml in the aqueous and 2.2 micrograms/ml in the vitreous. After the 300 mg dose, maximum levels were also achieved at 4 h, and were 5.0 micrograms/ml in the aqueous and 2.6 micrograms/ml in the vitreous. The 600 mg dose produced maximum levels at 6 h after administration, with 20.0 micrograms/ml in the aqueous and 15.2 micrograms/ml in the vitreous. These levels exceed the minimum inhibitory concentration for many microorganisms and suggest additional investigation into possible applications of systemic rifampin in the prophylaxis and treatment of bacterial endophthalmitis.
利福平是已知最强效的抗葡萄球菌药物,在给兔子单次口服150毫克、300毫克或600毫克后,检测了其在房水和玻璃体内的渗透情况。150毫克剂量后,4小时达到最高水平,房水中为4.2微克/毫升,玻璃体内为2.2微克/毫升。300毫克剂量后,同样在4小时达到最高水平,房水中为5.0微克/毫升,玻璃体内为2.6微克/毫升。600毫克剂量在给药后6小时达到最高水平,房水中为20.0微克/毫升,玻璃体内为15.2微克/毫升。这些水平超过了许多微生物的最低抑菌浓度,提示有必要进一步研究全身应用利福平在预防和治疗细菌性眼内炎方面的可能应用。